Internal Medicine

Investigators find that substitute salt better protects older people with a history of stroke or high blood pressure against secondary outcomes of cardiovascular events and death.

A recent study found no benefits of immediate angiography over a delayed or selective strategy with respect to the 30-day risk of death from any cause.

Investigators argue that outdated practice laws and other methods hinder physician assistants and nurse practitioners from providing the best patient care and utilizing their skills during the COVID-19 pandemic.

The authors of a recent review recommend continued research on “powerful” new treatment methods that are effective in treating atopic diseases such as atopic eczema.

Investigators believe their study shows the efficacy and safety of the 2 biologic agents, which are known to have anti-inflammatory and immunosuppressant qualities.

Investigators have found a negative association between the COPD and proton pump inhibitors through a familiar sequence symmetry analysis approach used to find associations between COPD and gastro-esophageal reflux disease.

Though operating room-based injections are predominantly performed, investigators could not find sufficient data that confirmed it as the only safe injection site.

New research shows 9 SNPs of 4 genes were significantly associated with the anti-VEGF therapy response in patients with age-related macular degeneration.

The new growth hormone has a weekly injection rate, as opposed to the daily injection rates of other growth hormones such as somatropin.

Clindamycin, fluoroquinolones, and ceftriaxone are associated with the highest risk of CDI.

Investigators believe the treatment strategy can go on to treat other “difficult-to-treat” areas of the body such as palms, elbows, and lips.

The study also showed cost savings for both standard and dose-intensified infliximab.

A new study shows that research and educational resources are greatly lacking regarding skin color and dermatology education.

Investigators found that patients who were not treated with biologic medications were at a significantly increased risk of developing psoriatic arthritis.

Though investigators called for more research on the biologic, recent data showed patients treated with bimekizumab recorded improved skin pain when compared to placebo and adalimumab.

A 0.063 mg dose had a probability of 94% to be ≥95% effective, despite being 4- to 10- times lower than common dosage levels.

Investigators found that intralymphatic immunotherapy of was not superior to placebo or other forms of allergen-specific immunotherapy, but felt continued research was warranted.

Investigators found that despite a lack of infrastructure on pediatric quality improvement, higher-performing hospitals can sustain cost-effective strategies for pediatric asthma care.

Data show 15% of authors in this analysis reported financial associations with trial sponsors in invasive cardiovascular intervention studies.

Developed by BrainsWay, the new device has been shown to decrease anxiety symptoms in adult patients with anxious depression.

Dr. LaMoreaux believes that to treat gout in patients with proper medications and therapies, doctors must first establish trust and combat the stigma surrounding this painful form of arthritis.

Though no research on the effects of positive emotion intervention on children with asthma exist, investigators note that the methods have shown positive results in other health contexts.

Recent data from phase 3 clinical trials of the antibody shows significant skin clearance and itch in people with atopic dermatitis.

A systematic review and meta-analysis of randomized clinical trial data suggest those adhering to diets with a low glycemic index and low glycemic load were linked to lowered HbA1c levels and improvements in cardiometabolic risk factors.

According to a claims analysis, sunburn was also commonly diagnosed in female and young patients.

With immunosuppressed populations at an increased risk of death and comorbidities due to COVID-19, members of the Advisory Committee of Immunization Practices moved to approve additional doses for young at-risk patients.

Women with COVID-19 who gave birth were more likely to deliver earlier than 37 weeks.

The combination agent breaks ground as the first treatment approved for this indication.

Staff from schools across the United Kingdom express desire for enhanced staff preparedness and internal allergy policy review after being surveyed by investigators.

Niemann-Pick is highly heterogenous and is characterized by hypervariable manifestations across patients.